These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2072670)

  • 41. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spasmodic Dysphonia.
    Lin J; Sadoughi B
    Adv Otorhinolaryngol; 2020; 85():133-143. PubMed ID: 33166970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Indications for botulinum toxin in laryngectomy].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of laryngeal muscle activation in patients with voice tremor.
    Koda J; Ludlow CL
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):684-96. PubMed ID: 1437206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multichannel electromyographic observations in spasmodic dysphonia patients and normal control subjects.
    Schaefer SD; Roark RM; Watson BC; Kondraske GV; Freeman FJ; Butsch RW; Pohl J
    Ann Otol Rhinol Laryngol; 1992 Jan; 101(1):67-75. PubMed ID: 1728888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscle tension dysphonia and spasmodic dysphonia: the role of manual laryngeal tension reduction in diagnosis and management.
    Roy N; Ford CN; Bless DM
    Ann Otol Rhinol Laryngol; 1996 Nov; 105(11):851-6. PubMed ID: 8916858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synchrony of laryngeal muscle activity in persons with vocal tremor.
    Finnegan EM; Luschei ES; Barkmeier JM; Hoffman HT
    Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):313-8. PubMed ID: 12622540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics.
    Davis PJ; Boone DR; Carroll RL; Darveniza P; Harrison GA
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):179-85. PubMed ID: 3355046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adductor spasmodic dysphonia versus muscle tension dysphonia: examining the diagnostic value of recurrent laryngeal nerve lidocaine block.
    Roy N; Smith ME; Allen B; Merrill RM
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):161-8. PubMed ID: 17419518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Singer's dystonia: first report of a variant of spasmodic dysphonia.
    Chitkara A; Meyer T; Keidar A; Blitzer A
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Abnormal adductor movement of the vocal cords in spasmodic dysphonia].
    Shibusawa M
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Apr; 96(4):659-64. PubMed ID: 8509938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
    Koufman JA; Rees CJ; Halum SL; Blalock D
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical investigations of adductor spastic dysphonia.
    Hartman DE; Abbs JH; Vishwanat B
    Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):247-52. PubMed ID: 3377392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading.
    Sapienza CM; Walton S; Murry T
    J Voice; 2000 Dec; 14(4):502-20. PubMed ID: 11130109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.
    Sapienza CM; Cannito MP; Murry T; Branski R; Woodson G
    J Speech Lang Hear Res; 2002 Oct; 45(5):830-43. PubMed ID: 12381042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.